142 related articles for article (PubMed ID: 36728675)
1. Comparative Study of Opioid Initiation With Tramadol, Short-acting Hydrocodone, or Short-acting Oxycodone on Opioid-related Adverse Outcomes Among Chronic Noncancer Pain Patients.
Acharya M; Hayes CJ; Li C; Painter JT; Dayer L; Martin BC
Clin J Pain; 2023 Mar; 39(3):107-118. PubMed ID: 36728675
[TBL] [Abstract][Full Text] [Related]
2. Opioid therapy trajectories of patients with chronic non-cancer pain over 1 year of follow-up after initiation of short-acting opioid formulations.
Acharya M; Hayes CJ; Li C; Painter JT; Dayer L; Martin BC
Pain Med; 2024 Mar; 25(3):173-186. PubMed ID: 38243702
[TBL] [Abstract][Full Text] [Related]
3. Development of a potential opioid misuse measure from administrative dispensing data and contrasting opioid misuse among individuals on long-term tramadol, long-term short-acting hydrocodone or long-term short-acting oxycodone therapy in Arkansas.
Acharya M; Hayes CJ; Li C; Painter JT; Dayer L; Martin BC
Curr Med Res Opin; 2022 Nov; 38(11):1947-1957. PubMed ID: 36000252
[TBL] [Abstract][Full Text] [Related]
4. Comparative safety of tramadol and other opioids following total hip and knee arthroplasty.
Bosco E; Riester MR; Beaudoin FL; Schoenfeld AJ; Gravenstein S; Mor V; Zullo AR
BMC Geriatr; 2024 Apr; 24(1):319. PubMed ID: 38580920
[TBL] [Abstract][Full Text] [Related]
5. Opioid-Induced Esophageal Dysfunction: Differential Effects of Type and Dose.
Snyder DL; Crowell MD; Horsley-Silva J; Ravi K; Lacy BE; Vela MF
Am J Gastroenterol; 2019 Sep; 114(9):1464-1469. PubMed ID: 31403963
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Opioids Prescribed for Patients at Risk for Opioid Misuse Before and After Publication of the Centers for Disease Control and Prevention's Opioid Prescribing Guidelines.
Scherrer JF; Tucker J; Salas J; Zhang Z; Grucza R
JAMA Netw Open; 2020 Dec; 3(12):e2027481. PubMed ID: 33263762
[TBL] [Abstract][Full Text] [Related]
7. Opioid-related overdose and chronic use following an initial prescription of hydrocodone versus oxycodone.
Weiner SG; Hendricks MA; El Ibrahimi S; Ritter GA; Hallvik SE; Hildebran C; Weiss RD; Boyer EW; Flores DP; Nelson LS; Kreiner PW; Fischer MA
PLoS One; 2022; 17(4):e0266561. PubMed ID: 35381052
[TBL] [Abstract][Full Text] [Related]
8. Individual short-acting opioids and the risk of opioid-related adverse events in adolescents.
Chung CP; Callahan ST; Cooper WO; Dupont WD; Murray KT; Franklin AD; Hall K; Dudley JA; Stein CM; Ray WA
Pharmacoepidemiol Drug Saf; 2019 Nov; 28(11):1448-1456. PubMed ID: 31418512
[TBL] [Abstract][Full Text] [Related]
9. Provider specialty and odds of a new codeine, hydrocodone, oxycodone and tramadol prescription before and after the CDC opioid prescribing guideline publication.
Tucker J; Salas J; Zhang Z; Grucza R; Scherrer JF
Prev Med; 2021 May; 146():106466. PubMed ID: 33636196
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of Prescription Opioid Analgesics in Pregnancy and Risk of Neonatal Opioid Withdrawal Syndrome in Newborns.
Esposito DB; Huybrechts KF; Werler MM; Straub L; Hernández-Díaz S; Mogun H; Bateman BT
JAMA Netw Open; 2022 Aug; 5(8):e2228588. PubMed ID: 36001312
[TBL] [Abstract][Full Text] [Related]
11. Chronic use of tramadol after acute pain episode: cohort study.
Thiels CA; Habermann EB; Hooten WM; Jeffery MM
BMJ; 2019 May; 365():l1849. PubMed ID: 31088782
[TBL] [Abstract][Full Text] [Related]
12. Commonly Initiated Opioids and Risk of Fracture Hospitalizations in United States Nursing Homes.
Hunnicutt JN; Hume AL; Liu SH; Ulbricht CM; Tjia J; Lapane KL
Drugs Aging; 2018 Oct; 35(10):925-936. PubMed ID: 30187291
[TBL] [Abstract][Full Text] [Related]
13. Impact of Hydrocodone Rescheduling on Dental Prescribing of Opioids.
Yan CH; Hubbard CC; Lee TA; Sharp LK; Evans CT; Calip GS; Rowan SA; McGregor JC; Gellad WF; Suda KJ
JDR Clin Trans Res; 2023 Oct; 8(4):402-412. PubMed ID: 35708454
[TBL] [Abstract][Full Text] [Related]
14. Association Between Commonly Prescribed Opioids and Androgen Deficiency in Men: A Retrospective Cohort Analysis.
Rubinstein AL; Carpenter DM
Pain Med; 2017 Apr; 18(4):637-644. PubMed ID: 27516365
[TBL] [Abstract][Full Text] [Related]
15. Trends in analgesic exposures reported to Texas Poison Centers following increased regulation of hydrocodone.
Haynes A; Kleinschmidt K; Forrester MB; Young A
Clin Toxicol (Phila); 2016 Jun; 54(5):434-40. PubMed ID: 26919555
[TBL] [Abstract][Full Text] [Related]
16. Opioids for cancer pain - an overview of Cochrane reviews.
Wiffen PJ; Wee B; Derry S; Bell RF; Moore RA
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012592. PubMed ID: 28683172
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness and Safety of Once-Daily Extended-Release Hydrocodone in Individuals Previously Receiving Immediate-Release Oxycodone for Chronic Pain.
Pergolizzi J; Kowalski M; He E
Pain Med; 2018 May; 19(5):967-977. PubMed ID: 28371835
[TBL] [Abstract][Full Text] [Related]
18. Long-term safety and effectiveness of once-daily, single-entity, extended-release hydrocodone over 76 weeks of an open-label study in patients with chronic noncancer and nonneuropathic pain.
Taber L; Lynch SY; He E; Ripa SR
Postgrad Med; 2016 Jan; 128(1):23-33. PubMed ID: 26681111
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the abuse liability of tramadol, NSAIDs, and hydrocodone in patients with chronic pain.
Adams EH; Breiner S; Cicero TJ; Geller A; Inciardi JA; Schnoll SH; Senay EC; Woody GE
J Pain Symptom Manage; 2006 May; 31(5):465-76. PubMed ID: 16716877
[TBL] [Abstract][Full Text] [Related]
20. Patterns in opioid prescription in the United States by region and prescribers over a 4-year period.
Bigal LM; Bibeau K; Dumbar S
J Opioid Manag; 2019; 15(6):499-506. PubMed ID: 31850512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
